Cargando…
Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response
A virulent recombinant HSV lacking the diploid γ(1)34.5 gene (Δγ(1)34.5) have been investigated over the last two decades both for anti-tumor therapy and as vaccine vectors. The first generation vectors, while safe, are incapable of sustained replication in the majority of treated patients. An inter...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185541/ https://www.ncbi.nlm.nih.gov/pubmed/21994558 http://dx.doi.org/10.3390/v1030510 |